| Year |
Citation |
Score |
| 2023 |
Santaliz-Casiano A, Mehta D, Danciu OC, Patel H, Banks L, Zaidi A, Buckley J, Rauscher GH, Schulte L, Weller LR, Taiym D, Liko-Hazizi E, Pulliam N, Friedewald SM, Khan S, ... ... Frasor J, et al. Identification of metabolic pathways contributing to ER breast cancer disparities using a machine-learning pipeline. Scientific Reports. 13: 12136. PMID 37495653 DOI: 10.1038/s41598-023-39215-1 |
0.471 |
|
| 2022 |
Semina SE, Alejo LH, Chopra S, Kansara NS, Kastrati I, Sartorius CA, Frasor J. Identification of a novel ER-NFĸB-driven stem-like cell population associated with relapse of ER+ breast tumors. Breast Cancer Research : Bcr. 24: 88. PMID 36482488 DOI: 10.1186/s13058-022-01585-1 |
0.554 |
|
| 2022 |
Pal P, Atilla-Gokcumen GE, Frasor J. Emerging Roles of Ceramides in Breast Cancer Biology and Therapy. International Journal of Molecular Sciences. 23. PMID 36232480 DOI: 10.3390/ijms231911178 |
0.82 |
|
| 2022 |
Smart E, Semina SE, Alejo LH, Kansara NS, Frasor J. Estrogen Receptor-Regulated Gene Signatures in Invasive Breast Cancer Cells and Aggressive Breast Tumors. Cancers. 14. PMID 35740514 DOI: 10.3390/cancers14122848 |
0.608 |
|
| 2022 |
Pal P, Millner A, Semina SE, Huggins RJ, Running L, Aga DS, Tonetti DA, Schiff R, Greene GL, Atilla-Gokcumen GE, Frasor J. Endocrine Therapy-Resistant Breast Cancer Cells Are More Sensitive to Ceramide Kinase Inhibition and Elevated Ceramide Levels Than Therapy-Sensitive Breast Cancer Cells. Cancers. 14. PMID 35625985 DOI: 10.3390/cancers14102380 |
0.824 |
|
| 2022 |
Semina SE, Pal P, Kansara NS, Huggins RJ, Alarid ET, Greene GL, Frasor J. Selective pressure of endocrine therapy activates the integrated stress response through NFκB signaling in a subpopulation of ER positive breast cancer cells. Breast Cancer Research : Bcr. 24: 19. PMID 35264224 DOI: 10.1186/s13058-022-01515-1 |
0.83 |
|
| 2020 |
Smart E, Semina SE, Frasor J. Update on the role of NFκB in promoting aggressive phenotypes of estrogen receptor (ER) positive breast cancer. Endocrinology. 161. PMID 32887995 DOI: 10.1210/Endocr/Bqaa152 |
0.628 |
|
| 2020 |
Hases L, Indukuri R, Birgersson M, Nguyen-Vu T, Lozano R, Saxena A, Hartman J, Frasor J, Gustafsson JÅ, Katajisto P, Archer A, Williams C. Intestinal estrogen receptor beta suppresses colon inflammation and tumorigenesis in both sexes. Cancer Letters. PMID 32711097 DOI: 10.1016/J.Canlet.2020.06.021 |
0.417 |
|
| 2020 |
Kastrati I, Joosten SEP, Semina SE, Alejo LH, Brovkovych SD, Stender JD, Horlings HM, Kok M, Alarid ET, Greene GL, Linn SC, Zwart W, Frasor J. The NFκB pathway promotes tamoxifen tolerance and disease recurrence in estrogen receptor positive breast cancers. Molecular Cancer Research : McR. PMID 32245803 DOI: 10.1158/1541-7786.Mcr-19-1082 |
0.84 |
|
| 2020 |
Smart E, Alejo LH, Frasor J. Cytoplasmic ERα and NFκB Promote Cell Survival in Mouse Mammary Cancer Cell Lines. Hormones and Cancer. 11: 76-86. PMID 32008217 DOI: 10.1007/S12672-020-00378-2 |
0.638 |
|
| 2020 |
Hases L, Indukuri R, Birgersson M, Nguyen-Vu T, Lozano R, Saxena A, Hartman J, Frasor J, Gustafsson J, Katajisto P, Archer A, Williams C. Abstract 2081: Intestinal estrogen receptor beta suppresses colon inflammation and tumorigenesis in both sexes Epidemiology. DOI: 10.1158/1538-7445.Am2020-2081 |
0.352 |
|
| 2020 |
Danciu OC, Chlipala G, Madak-Erdogan Z, Patel H, Banks L, Zaidi A, Santaliz-Casiano A, Schulte L, Weller L, Taiym D, Pulliam N, Hazizi EL, Martin E, Fareeduddin A, Bargaje A, ... ... Frasor J, et al. Abstract 1176: Racial differences in circulating inflammatory cytokines and breast cancer disparities Epidemiology. DOI: 10.1158/1538-7445.Am2020-1176 |
0.515 |
|
| 2019 |
He C, Danes JM, Hart PC, Zhu Y, Huang Y, de Abreu AL, O'Brien J, Mathison AJ, Tang B, Frasor JM, Wakefield LM, Ganini D, Stauder E, Zielonka J, Gantner BN, et al. SOD2 acetylation on lysine 68 promotes stem cell reprogramming in breast cancer. Proceedings of the National Academy of Sciences of the United States of America. PMID 31591207 DOI: 10.1073/Pnas.1902308116 |
0.5 |
|
| 2019 |
Moore TW, Frasor J. Editorial for Special Issue on "Alternative Nuclear Receptor Ligands". Molecular and Cellular Endocrinology. 110479. PMID 31173820 DOI: 10.1016/J.Mce.2019.110479 |
0.311 |
|
| 2019 |
Aboukhatwa SM, Hanigan TW, Taha TY, Neerasa J, Ranjan R, El-Bastawissy EE, Elkersh MA, El-Moselhy TF, Frasor J, Mahmud N, McLachlan A, Petukhov PA. Structurally Diverse Histone Deacetylase Photoreactive Probes: Design, Synthesis, and Photolabeling Studies in Live Cells and Tissue. Chemmedchem. PMID 30921497 DOI: 10.1002/Cmdc.201900114 |
0.31 |
|
| 2019 |
Brovkovych V, Aldrich A, Li N, Atilla‐Gokcumen GE, Frasor J. Removal of Serum Lipids and Lipid-Derived Metabolites to Investigate Breast Cancer Cell Biology. Proteomics. 19: 1800370. PMID 30919589 DOI: 10.1002/Pmic.201800370 |
0.41 |
|
| 2019 |
Casiano AMS, Madak-Erdogan Z, Danciu O, Patel H, Banks L, Buckley J, Rauscher G, Fareeduddin A, Martin E, Bargaje A, Garcia C, Schulte L, Taiym D, Kim J, Gradishar W, ... ... Frasor J, et al. Abstract 4208: Integrated molecular approach to identify biological factors contributing to breast cancer disparities in Chicago Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7445.Sabcs18-4208 |
0.494 |
|
| 2019 |
Brovkovych V, Aldrich A, Li N, Atilla‐Gokcumen GE, Frasor J. Front Cover: Removal of Serum Lipids and Lipid‐Derived Metabolites to Investigate Breast Cancer Cell Biology Proteomics. 19: 1970161. DOI: 10.1002/Pmic.201970161 |
0.515 |
|
| 2018 |
Brovkovych V, Izhar Y, Danes JM, Dubrovskyi O, Sakallioglu IT, Morrow LM, Atilla-Gokcumen GE, Frasor J. Fatostatin induces pro- and anti-apoptotic lipid accumulation in breast cancer. Oncogenesis. 7: 66. PMID 30140005 DOI: 10.1038/s41389-018-0076-0 |
0.533 |
|
| 2018 |
Speltz TE, Danes JM, Stender JD, Frasor J, Moore TW. A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction. Acs Chemical Biology. PMID 29309722 DOI: 10.1021/Acschembio.7B01016 |
0.796 |
|
| 2018 |
Aboukhatwa SM, Hanigan TW, Neerasa J, Taha TY, Brown ND, El-Bastawissy EE, Elkersh MA, El-Moselhy TF, Frasor J, Petukhov PA. Abstract 5801: Unexpected selectivity of histone deacetylase inhibitors in live MDA-MD-231 triple-negative breast cancer cells Cancer Research. 78: 5801-5801. DOI: 10.1158/1538-7445.Am2018-5801 |
0.489 |
|
| 2018 |
Kastrati I, Brovkovych SD, Stender JD, Alarid ET, Frasor J. Abstract 5242: NFĸB pathway activation is a key determinant of tamoxifen tolerance and recurrence in breast cancer Cancer Research. 78: 5242-5242. DOI: 10.1158/1538-7445.Am2018-5242 |
0.834 |
|
| 2018 |
Smart E, Kastrati I, Frasor J. Abstract 2158: Inhibition of NFkB restores tamoxifen responsiveness in resistant estrogen receptor positive breast cancer in a syngeneic mouse model Cancer Research. 78: 2158-2158. DOI: 10.1158/1538-7445.Am2018-2158 |
0.647 |
|
| 2018 |
Speltz TE, Danes JM, Fanning SW, Mayne CG, Tajkhorshid E, Greene GL, Frasor JM, Moore TW. Abstract 1810: Stapled peptide inhibitors of mutant estrogen receptor/coactivator interactions Cancer Research. 78: 1810-1810. DOI: 10.1158/1538-7445.Am2018-1810 |
0.491 |
|
| 2017 |
El-Shennawy L, Dubrovskyi O, Kastrati I, Danes JM, Zhang Y, Whiteley HE, Creighton CJ, Frasor J. Coactivation of estrogen receptor and IKK-β induces a dormant metastatic phenotype in ER-positive breast cancer. Cancer Research. PMID 29229606 DOI: 10.1158/0008-5472.Can-17-1686 |
0.641 |
|
| 2017 |
Hanigan TW, Taha TY, Aboukhatwa SM, Frasor J, Petukhov PA. Scaffold dependent histone deacetylase (HDAC) inhibitor induced re-equilibration of the subcellular localization and post-translational modification state of class I HDACs. Plos One. 12: e0186620. PMID 29045501 DOI: 10.1371/Journal.Pone.0186620 |
0.348 |
|
| 2017 |
Hanigan TW, Aboukhatwa SM, Taha TY, Frasor J, Petukhov PA. Divergent JNK Phosphorylation of HDAC3 in Triple-Negative Breast Cancer Cells Determines HDAC Inhibitor Binding and Selectivity. Cell Chemical Biology. PMID 28943357 DOI: 10.1016/J.Chembiol.2017.08.015 |
0.483 |
|
| 2017 |
Srinivasan S, Nwachukwu JC, Bruno NE, Dharmarajan V, Goswami D, Kastrati I, Novick S, Nowak J, Cavett V, Zhou HB, Boonmuen N, Zhao Y, Min J, Frasor J, Katzenellenbogen BS, et al. Corrigendum: Full antagonism of the estrogen receptor without a prototypical ligand side chain. Nature Chemical Biology. 13: 691. PMID 28514424 DOI: 10.1038/Nchembio0617-691C |
0.465 |
|
| 2017 |
Srinivasan S, Nwachukwu JC, Bruno NE, Dharmarajan V, Goswami D, Kastrati I, Novick S, Nowak J, Cavett V, Zhou HB, Boonmuen N, Zhao Y, Min J, Frasor J, Katzenellenbogen BS, et al. Erratum: Full antagonism of the estrogen receptor without a prototypical ligand side chain. Nature Chemical Biology. 13: 691. PMID 28514419 DOI: 10.1038/nchembio0617-691b |
0.485 |
|
| 2017 |
Kastrati I, Siklos MI, Brovkovych SD, Thatcher GR, Frasor J. A Novel Strategy to Co-target Estrogen Receptor and Nuclear Factor κB Pathways with Hybrid Drugs for Breast Cancer Therapy. Hormones & Cancer. PMID 28396978 DOI: 10.1007/S12672-017-0294-5 |
0.612 |
|
| 2017 |
Stender JD, Nwachukwu JC, Kastrati I, Kim Y, Strid T, Yakir M, Srinivasan S, Nowak J, Izard T, Rangarajan ES, Carlson KE, Katzenellenbogen JA, Yao XQ, Grant BJ, Leong HS, ... ... Frasor J, et al. Structural and Molecular Mechanisms of Cytokine-Mediated Endocrine Resistance in Human Breast Cancer Cells. Molecular Cell. 65: 1122-1135.e5. PMID 28306507 DOI: 10.1016/J.Molcel.2017.02.008 |
0.806 |
|
| 2017 |
Rauscher GH, Silva A, Pauls H, Frasor J, Bonini MG, Hoskins K. Racial disparity in survival from estrogen and progesterone receptor-positive breast cancer: implications for reducing breast cancer mortality disparities. Breast Cancer Research and Treatment. PMID 28251385 DOI: 10.1007/S10549-017-4166-Z |
0.588 |
|
| 2017 |
Kastrati I, Delgado-Rivera L, Georgieva G, Thatcher GR, Frasor J. Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells. Journal of Visualized Experiments : Jove. PMID 28190074 DOI: 10.3791/54798 |
0.509 |
|
| 2016 |
Srinivasan S, Nwachukwu JC, Bruno NE, Dharmarajan V, Goswami D, Kastrati I, Novick S, Nowak J, Cavett V, Zhou HB, Boonmuen N, Zhao Y, Min J, Frasor J, Katzenellenbogen BS, et al. Full antagonism of the estrogen receptor without a prototypical ligand side chain. Nature Chemical Biology. PMID 27870835 DOI: 10.1038/Nchembio.2236 |
0.635 |
|
| 2016 |
Kastrati I, Siklos MI, Calderon-Gierszal EL, El-Shennawy L, Georgieva G, Thayer EN, Thatcher GR, Frasor J. Dimethyl Fumarate Inhibits the Nuclear Factor κB Pathway in Breast Cancer Cells by Covalent Modification of p65 Protein. The Journal of Biological Chemistry. 291: 3639-47. PMID 26683377 DOI: 10.1074/Jbc.M115.679704 |
0.574 |
|
| 2016 |
Kastrati I, Siklos MI, Calderon-Gierszal EL, Thatcher GRJ, Frasor J. Abstract 4716: Dimethyl fumarate impairs breast cancer growth and inhibits the nuclear factor κB pathway in breast cancer cells by covalent modification of p65 Cancer Research. 76: 4716-4716. DOI: 10.1158/1538-7445.Am2016-4716 |
0.607 |
|
| 2016 |
Moore TW, Speltz TE, Fanning SW, Mayne CG, Frasor J, Greene GL, Tajkhorshid E. Abstract 3104: Stapled peptide inhibitors of the estrogen receptor/steroid receptor coactivator interaction Cancer Research. 76: 3104-3104. DOI: 10.1158/1538-7445.Am2016-3104 |
0.493 |
|
| 2015 |
Emmadi R, Canestrari E, Arbieva ZH, Mu W, Dai Y, Frasor J, Wiley E. Correlative Analysis of miRNA Expression and Oncotype Dx Recurrence Score in Estrogen Receptor Positive Breast Carcinomas. Plos One. 10: e0145346. PMID 26717565 DOI: 10.1371/Journal.Pone.0145346 |
0.455 |
|
| 2015 |
Kastrati I, Litosh VA, Zhao S, Alvarez M, Thatcher GR, Frasor J. A novel aspirin prodrug inhibits NFκB activity and breast cancer stem cell properties. Bmc Cancer. 15: 845. PMID 26530254 DOI: 10.1186/S12885-015-1868-7 |
0.544 |
|
| 2015 |
Frasor J, El-Shennawy L, Stender JD, Kastrati I. NFκB affects estrogen receptor expression and activity in breast cancer through multiple mechanisms. Molecular and Cellular Endocrinology. 418: 235-9. PMID 25450861 DOI: 10.1016/J.Mce.2014.09.013 |
0.831 |
|
| 2015 |
Kastrati I, Canestrari E, Frasor J. PHLDA1 expression is controlled by an estrogen receptor-NFκB-miR-181 regulatory loop and is essential for formation of ER+ mammospheres Oncogene. 34: 2309-2316. PMID 24954507 DOI: 10.1038/Onc.2014.180 |
0.549 |
|
| 2015 |
Kastrati I, Siklos M, Litosh V, Thatcher G, Frasor J. Abstract 4497: Design and synthesis of hybrid drugs to target inflammatory pathways in breast cancer Cancer Research. 75: 4497-4497. DOI: 10.1158/1538-7445.Am2015-4497 |
0.58 |
|
| 2015 |
El-Shennawy L, Frasor J. Abstract 1866: Constitutively active NF-κB signaling switches estrogen receptor positive breast cancer cells from a proliferative to an invasive phenotype through luminal/basal plasticity Cancer Research. 75: 1866-1866. DOI: 10.1158/1538-7445.Am2015-1866 |
0.628 |
|
| 2014 |
Stender JD, Kastrati I, Yakir M, Frasor J, Glass CK. Abstract LB-148: Inflammatory cytokines alter the sensitivity of breast cancer cells to endocrine treatments Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Lb-148 |
0.822 |
|
| 2013 |
Felice DL, El-Shennawy L, Zhao S, Lantvit DL, Shen Q, Unterman TG, Swanson SM, Frasor J. Growth hormone potentiates 17β-estradiol-dependent breast cancer cell proliferation independently of IGF-I receptor signaling. Endocrinology. 154: 3219-27. PMID 23782942 DOI: 10.1210/En.2012-2208 |
0.59 |
|
| 2013 |
Bergamaschi A, Frasor J, Borgen K, Stanculescu A, Johnson P, Rowland K, Wiley EL, Katzenellenbogen BS. 14-3-3ζ as a predictor of early time to recurrence and distant metastasis in hormone receptor-positive and -negative breast cancers. Breast Cancer Research and Treatment. 137: 689-96. PMID 23271328 DOI: 10.1007/S10549-012-2390-0 |
0.648 |
|
| 2012 |
Baumgarten SC, Frasor J. Minireview: Inflammation: An Instigator of More Aggressive Estrogen Receptor (ER) Positive Breast Cancers Molecular Endocrinology. 26: 360-371. PMID 22301780 DOI: 10.1210/Me.2011-1302 |
0.618 |
|
| 2012 |
Pradhan M, Baumgarten SC, Bembinster LA, Frasor J. CBP Mediates NF-κB-Dependent Histone Acetylation and Estrogen Receptor Recruitment to an Estrogen Response Element in the BIRC3 Promoter Molecular and Cellular Biology. 32: 569-575. PMID 22083956 DOI: 10.1128/Mcb.05869-11 |
0.832 |
|
| 2012 |
Bergamaschi A, Frasor JM, Borgen K, Stanculescu A, Johnson P, Rowland K, Wiley EL, Katzenellenbogen BS. Abstract 434: Identification of 14-3-3α as a predictor of early time to recurrence and a molecular target in metastatic hormone receptor-positive and -negative breast cancers Cancer Research. 72: 434-434. DOI: 10.1158/1538-7445.Am2012-434 |
0.671 |
|
| 2012 |
Zhao S, Frasor J. Abstract 4248: A high-fat diet induces an inflammatory tumor microenvironment in MNU-induced estrogen receptor positive mammary tumors Cancer Research. 72: 4248-4248. DOI: 10.1158/1538-7445.Am2012-4248 |
0.366 |
|
| 2012 |
Felice DL, Unterman TG, Swanson SM, Frasor J. Abstract 3923: Growth hormone activates ERK via EGFR, not IGF-IR, to potentiate estrogen-dependent breast cancer cell proliferation Cancer Research. 72: 3923-3923. DOI: 10.1158/1538-7445.Am2012-3923 |
0.564 |
|
| 2012 |
Kastrati I, Litosh VA, Thatcher GRJ, Frasor J. Abstract 3732: New aspirin analogs for targeted therapy of ER+ breast cancers with activated NFkB inflammatory pathway Cancer Research. 72: 3732-3732. DOI: 10.1158/1538-7445.Am2012-3732 |
0.641 |
|
| 2011 |
Huang L, Zhao S, Frasor JM, Dai Y. An integrated bioinformatics approach identifies elevated cyclin E2 expression and E2F activity as distinct features of tamoxifen resistant breast tumors. Plos One. 6: e22274. PMID 21789246 DOI: 10.1371/Journal.Pone.0022274 |
0.578 |
|
| 2011 |
Shehu A, Albarracin C, Sangeeta Devi Y, Luther K, Halperin J, Le J, Mao J, Duan RW, Frasor J, Gibori G. The stimulation of hsd17b7 expression by estradiol provides a powerful feed-forward mechanism for estradiol biosynthesis in breast cancer cells Molecular Endocrinology. 25: 754-766. PMID 21372145 DOI: 10.1210/Me.2010-0261 |
0.856 |
|
| 2010 |
Stanculescu A, Bembinster LA, Borgen K, Bergamaschi A, Wiley E, Frasor J. Estrogen promotes breast cancer cell survival in an inhibitor of apoptosis (IAP)-dependent manner Hormones and Cancer. 1: 127-135. PMID 21152357 DOI: 10.1007/S12672-010-0018-6 |
0.659 |
|
| 2010 |
Pradhan M, Bembinster LA, Baumgarten SC, Frasor J. Proinflammatory Cytokines Enhance Estrogen-dependent Expression of the Multidrug Transporter Gene ABCG2 through Estrogen Receptor and NFκB Cooperativity at Adjacent Response Elements Journal of Biological Chemistry. 285: 31100-31106. PMID 20705611 DOI: 10.1074/Jbc.M110.155309 |
0.847 |
|
| 2010 |
Han H, Frasor J, Tonetti D. Abstract 4608: Overexpression of PKCα alters gene expression pattern in T47D breast cancer cells associated with hormone-independent growth and tamoxifen resistance Endocrinology. 70: 4608-4608. DOI: 10.1158/1538-7445.Am10-4608 |
0.56 |
|
| 2009 |
Frasor J, Weaver A, Pradhan M, Dai Y, Miller LD, Lin CY, Stanculescu A. Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer. Cancer Research. 69: 8918-25. PMID 19920189 DOI: 10.1158/0008-5472.Can-09-2608 |
0.842 |
|
| 2008 |
Frasor J, Weaver AE, Pradhan M, Mehta K. Synergistic up-regulation of prostaglandin E synthase expression in breast cancer cells by 17beta-estradiol and proinflammatory cytokines. Endocrinology. 149: 6272-9. PMID 18703630 DOI: 10.1210/En.2008-0352 |
0.839 |
|
| 2007 |
Overk CR, Peng KW, Asghodom RT, Kastrati I, Lantvit DD, Qin Z, Frasor J, Bolton JL, Thatcher GR. Structure-activity relationships for a family of benzothiophene selective estrogen receptor modulators including raloxifene and arzoxifene. Chemmedchem. 2: 1520-6. PMID 17654759 DOI: 10.1002/Cmdc.200700104 |
0.541 |
|
| 2007 |
Stender JD, Frasor J, Komm B, Chang KC, Kraus WL, Katzenellenbogen BS. Estrogen-regulated gene networks in human breast cancer cells: involvement of E2F1 in the regulation of cell proliferation. Molecular Endocrinology (Baltimore, Md.). 21: 2112-23. PMID 17550982 DOI: 10.1210/Me.2006-0474 |
0.854 |
|
| 2006 |
Frasor J, Chang EC, Komm B, Lin CY, Vega VB, Liu ET, Miller LD, Smeds J, Bergh J, Katzenellenbogen BS. Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome. Cancer Research. 66: 7334-40. PMID 16849584 DOI: 10.1158/0008-5472.Can-05-4269 |
0.814 |
|
| 2006 |
Chang EC, Frasor J, Komm B, Katzenellenbogen BS. Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells. Endocrinology. 147: 4831-42. PMID 16809442 DOI: 10.1210/En.2006-0563 |
0.813 |
|
| 2005 |
Frasor J, Danes JM, Funk CC, Katzenellenbogen BS. Estrogen down-regulation of the corepressor N-CoR: mechanism and implications for estrogen derepression of N-CoR-regulated genes. Proceedings of the National Academy of Sciences of the United States of America. 102: 13153-7. PMID 16141343 DOI: 10.1073/Pnas.0502782102 |
0.639 |
|
| 2005 |
Rai D, Frolova A, Frasor J, Carpenter AE, Katzenellenbogen BS. Distinctive actions of membrane-targeted versus nuclear localized estrogen receptors in breast cancer cells. Molecular Endocrinology (Baltimore, Md.). 19: 1606-17. PMID 15831524 DOI: 10.1210/Me.2004-0468 |
0.713 |
|
| 2004 |
Katzenellenbogen BS, Frasor J. Therapeutic targeting in the estrogen receptor hormonal pathway. Seminars in Oncology. 31: 28-38. PMID 15052541 DOI: 10.1053/J.Seminoncol.2004.01.004 |
0.753 |
|
| 2004 |
Stossi F, Barnett DH, Frasor J, Komm B, Lyttle CR, Katzenellenbogen BS. Transcriptional profiling of estrogen-regulated gene expression via estrogen receptor (ER) alpha or ERbeta in human osteosarcoma cells: distinct and common target genes for these receptors. Endocrinology. 145: 3473-86. PMID 15033914 DOI: 10.1210/En.2003-1682 |
0.638 |
|
| 2004 |
Frasor J, Stossi F, Danes JM, Komm B, Lyttle CR, Katzenellenbogen BS. Selective estrogen receptor modulators: discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells. Cancer Research. 64: 1522-33. PMID 14973112 DOI: 10.1158/0008-5472.Can-03-3326 |
0.739 |
|
| 2003 |
Frasor J, Danes JM, Komm B, Chang KC, Lyttle CR, Katzenellenbogen BS. Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology. 144: 4562-74. PMID 12959972 DOI: 10.1210/En.2003-0567 |
0.726 |
|
| 2003 |
Frasor J, Barnett DH, Danes JM, Hess R, Parlow AF, Katzenellenbogen BS. Response-specific and ligand dose-dependent modulation of estrogen receptor (ER) alpha activity by ERbeta in the uterus. Endocrinology. 144: 3159-66. PMID 12810572 DOI: 10.1210/En.2002-0143 |
0.633 |
|
| 2003 |
Frasor J, Gibori G. Prolactin regulation of estrogen receptor expression. Trends in Endocrinology and Metabolism: Tem. 14: 118-23. PMID 12670737 DOI: 10.1016/S1043-2760(03)00030-4 |
0.699 |
|
| 2003 |
Rajendran RR, Nye AC, Frasor J, Balsara RD, Martini PG, Katzenellenbogen BS. Regulation of nuclear receptor transcriptional activity by a novel DEAD box RNA helicase (DP97). The Journal of Biological Chemistry. 278: 4628-38. PMID 12466272 DOI: 10.1074/Jbc.M210066200 |
0.804 |
|
| 2002 |
Frasor J, Park K, Byers M, Telleria C, Kitamura T, Yu-Lee LY, Djiane J, Park-Sarge OK, Gibori G. Differential roles for signal transducers and activators of transcription 5a and 5b in PRL stimulation of ERalpha and ERbeta transcription. Molecular Endocrinology (Baltimore, Md.). 15: 2172-81. PMID 11731618 DOI: 10.1210/Mend.15.12.0745 |
0.67 |
|
| 2001 |
Frasor J, Barkai U, Zhong L, Fazleabas AT, Gibori G. PRL-induced ERα gene expression is mediated by Janus kinase 2 (Jak2) while signal transducer and activator of transcription 5b (Stat5b) phosphorylation involves Jak2 and a second tyrosine kinase Molecular Endocrinology. 15: 1941-1952. PMID 11682625 DOI: 10.1210/Mend.15.11.0722 |
0.608 |
|
| 1999 |
Frasor J, Gaspar CA, Donnelly KM, Gibori G, Fazleabas AT. Expression of prolactin and its receptor in the baboon uterus during the menstrual cycle and pregnancy Journal of Clinical Endocrinology and Metabolism. 84: 3344-3350. PMID 10487709 DOI: 10.1210/Jcem.84.9.5948 |
0.594 |
|
| 1998 |
Zhong L, Ou J, Barkai U, Mao JF, Frasor J, Gibori G. Molecular Cloning and Characterization of the Rat Ovarian 20α-Hydroxysteroid Dehydrogenase Gene Biochemical and Biophysical Research Communications. 249: 797-803. PMID 9731216 DOI: 10.1006/Bbrc.1998.9229 |
0.325 |
|
| Show low-probability matches. |